Metabolic Disease Drug Development
23 Oct 2012 - 25 Oct 2012 - Boston, MA, USA
Metabolic Disease Drug Development guarantees strong representation and candid discussion from senior level figures at Pfizer, Merck, BMS and the most innovative biotechs in the field. It will provide valuable insight into identifying and validating new metabolic drug targets, streamlining clinical strategy and speeding the passage of your drugs to market.
Attend this meeting to answer these questions:
- Where will innovation come from in the metabolic drug pipeline?
- What clinical strategies will satisfy regulators?